3rd Annual Neurology Pharmacology Made Simple Symposium
The Ohio State University Wexner Medical Center Department of Neurology is proud to offer the 3rd annual symposium for advanced practice providers (APP) – Neurology Pharmacology Made Simple. This symposium is free to Ohio State faculty, staff and students, and will take place Friday, May 17, 2024 from 8:00 a.m. – 4:30 p.m. Attendees will be able to either attend in-person at the Fawcett Center or virtually.
Our keynote speaker, Shannon Anderson, MPAS, PA-C, from Oregon Health & Science University, will speak on the management of Parkinson’s disease. Additional sessions will be led by advanced practice providers and will address strategies, guidelines and pharmacologic advancements to help manage some of the most common neurological topics seen in primary care and specialty clinics.
Continuing education credits are available for those who attend. Please see the Continuing Education section of the registration website for more information.
Past Events
Ohio State Neurology Update – Comprehensive Review for the Clinician
February 3, 2024 | 8:00 a.m. – 5:00 p.m.
This CME-accredited symposium will provide information on latest diagnostic guidelines and clinical management approaches for a range of common neurological diseases and conditions, including stroke, headache, memory disorders, Parkinson’s Disease, neuromuscular disorders, multiple sclerosis and epilepsy. Each talk will be given by a nationally recognized specialist in the field. A panel of experts will also review ongoing and upcoming clinical trials and studies of novel disease modifying agents for individuals with migraines, MS, neuromuscular disorders, seizures, Parkinson’s Disease, and Alzheimer’s disease and other forms of dementia. This event offers both virtual and in-person attendance.
The Ohio State University designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Learn more about the CME credits available.
2023 Neurology DEI Symposium
October 13, 2023 | 8:00 a.m. – 6:00 p.m.
The Ohio State University Wexner Medical Center Department of Neurology is proud to offer its inaugural Diversity Equity and Inclusion Symposium. The goal of this symposium is to bring awareness to challenges to advancement in underrepresented groups in medicine, provide career development guidance to trainees, and foster collaboration and mentorship. Attendees will have an opportunity to attend lecture presentations and panel discussions given by experts and leaders in neurology and DEI, as well as networking opportunities.
Neurology Pharmacology Made Simple
May 19, 2023 | 8:00 a.m. – 4:30 p.m.
The Department of Neurology is proud to offer the 2nd annual neurology symposium for advanced practice providers (APP) – Neurology Pharmacology Made Simple. This symposium will take place Friday, May 19, 2023 from 8:00 a.m. – 4:30 p.m. Attendees will be able to either attend in-person at the Fawcett Center or virtually. Our keynote speaker, North Carolina Senator Gale Adcock RN, MSN, FNP-BC, FAANP, FAAN, will present "Off the Sidelines and Into the Game." Additional sessions will be led by advanced practice providers and will address strategies, guidelines and pharmacologic advancements to help manage some of the most common neurological topics seen in primary care and specialty clinics
Ohio State Neurology Update – Comprehensive Review for the Clinician
January 21, 2023 | 8:00 a.m. – 5:00 p.m.
This CME-accredited symposium will provide information on latest diagnostic guidelines and clinical management approaches for a range of common neurological diseases and conditions, including headache, memory disorders, Parkinson’s Disease, neuropathy, multiple sclerosis and epilepsy. Each talk will be given by a nationally recognized specialist in the field. Cutting edge developments in holistic, multidisciplinary care will be discussed, with a focus on innovative customized, and multidisciplinary symptom management, clinics. A panel of experts will review ongoing and upcoming clinical trials and studies of novel disease modifying agents for individuals with migraines, MS, neuromuscular disorders, seizures, Parkinson’s Disease, and Alzheimer’s disease and other forms of dementia. This event offers both virtual and in-person attendance.